WuXi PharmaTech Launches Talent Flow with Acquired U.S. Firm AppTec
This article was originally published in PharmAsia News
Executive Summary
BEIJING - WuXi PharmaTech, one of China's leading contract research organizations, is moving rapidly to integrate operations and foster a talent flow with its recently acquired American biologics outfit AppTec Laboratory Services